ALA 1.79% 14.3¢ arovella therapeutics limited

indicators starting to turn, page-3

  1. 2,560 Posts.
    lightbulb Created with Sketch. 1
    The next 2 weeks will be very interesting for the company.Possibly the most significant exposure for suda in its history will be at the forthcoming BIO-Europe conference in Turin between 10-12 March.While suda has taken on some clout by engaging Torreya,the prospect of having all the major Pharma companies there looking for partnerships will offer suda some great exposure.We should get some real tangible insight about the potential of the company by the interest that is generated.Any real interest in just one product in its pipeline would validated the prospects of all its existing pipeline and other products to come.
    So for me the next 2 weeks suda should be exciting not so much because of the "indicators",though they may great rather because of the exposure.
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
(20min delay)
Last
14.3¢
Change
0.003(1.79%)
Mkt cap ! $152.4M
Open High Low Value Volume
14.5¢ 14.5¢ 14.0¢ $39.01K 271.6K

Buyers (Bids)

No. Vol. Price($)
12 554409 14.0¢
 

Sellers (Offers)

Price($) Vol. No.
14.5¢ 392875 10
View Market Depth
Last trade - 11.22am 10/07/2024 (20 minute delay) ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.